Gene · 9134
Papers2,792
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,792
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A co-formulation of interferons alpha2b and gamma distinctively targets cell cycle in the glioblastoma-derived cell line U-87MG. | BMC Cancer | 2023 | 37644431 | PubTator, text mining | PubMed |
| Homeobox Gene Expression Dysregulation as Potential Diagnostic and Prognostic Biomarkers in Bladder Cancer. | Diagnostics (Basel) | 2023 | 37627900 | PubTator, text mining | PubMed |
| Chromosomal instability and a deregulated cell cycle are intrinsic features of high-risk gastrointestinal stromal tumours with a metastatic potential. | Mol Oncol | 2023 | 37622176 | PubTator, text mining | PubMed |
| FOXM1 maintains fatty acid homoeostasis through the SET7-H3K4me1-FASN axis. | Cell Death Discov | 2023 | 37620304 | PubTator, text mining | PubMed |
| RNA modification: mechanisms and therapeutic targets. | Mol Biomed | 2023 | 37612540 | PubTator, text mining | PubMed |
| Construction of stemness gene score by bulk and single-cell transcriptome to characterize the prognosis of breast cancer. | Aging (Albany NY) | 2023 | 37602872 | PubTator, text mining | PubMed |
| Role of microRNAs in Chronic Lymphocytic Leukemia. | Int J Mol Sci | 2023 | 37569845 | PubTator, text mining | PubMed |
| Interruption of p53-MDM2 Interaction by Nutlin-3a in Human Lymphoma Cell Models Initiates a Cell-Dependent Global Effect on Transcriptome and Proteome Level. | Cancers (Basel) | 2023 | 37568720 | PubTator, text mining | PubMed |
| Steroidal Saponins: Naturally Occurring Compounds as Inhibitors of the Hallmarks of Cancer. | Cancers (Basel) | 2023 | 37568716 | PubTator, text mining | PubMed |
| Radiomic predicts early response to CDK4/6 inhibitors in hormone receptor positive metastatic breast cancer. | NPJ Breast Cancer | 2023 | 37567880 | PubTator, text mining | PubMed |
| UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma. | Cancer Med | 2023 | 37563971 | PubTator, text mining | PubMed |
| Expression of genes regulating cell division in porcine follicular granulosa cells. | Cell Div | 2023 | 37550786 | PubTator, text mining | PubMed |
| Multiomics analyses reveal DARS1-AS1/YBX1-controlled posttranscriptional circuits promoting glioblastoma tumorigenesis/radioresistance. | Sci Adv | 2023 | 37540752 | PubTator, text mining | PubMed |
| Transcriptome-wide association study-derived genes as potential visceral adipose tissue-specific targets for type 2 diabetes. | Diabetologia | 2023 | 37540242 | PubTator, text mining | PubMed |
| Extracellular vesicles in the treatment and diagnosis of breast cancer: a status update. | Front Endocrinol (Lausanne) | 2023 | 37534210 | PubTator, text mining | PubMed |
| Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis. | Turk J Biol | 2023 | 37529110 | PubTator, text mining | PubMed |
| Exosomes promote hFOB1.19 proliferation and differentiation via LINC00520. | J Orthop Surg Res | 2023 | 37516879 | PubTator, text mining | PubMed |
| New Gene Markers of Exosomal Regulation Are Involved in Porcine Granulosa Cell Adhesion, Migration, and Proliferation. | Int J Mol Sci | 2023 | 37511632 | PubTator, text mining | PubMed |
| CDK4/6 Inhibitor Resistance in Hormone Receptor-Positive Metastatic Breast Cancer: Translational Research, Clinical Trials, and Future Directions. | Int J Mol Sci | 2023 | 37511548 | PubTator, text mining | PubMed |
| ZFP57 promotes ovarian cancer progression by transcriptionally regulating BRCA1 and managing G1 checkpoint. | J Cancer | 2023 | 37497403 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9134/papers?page=9